Uncategorized

Mirava Bio is now live in the Netherlands: introducing Mirava Bio BV

We are pleased to announce Mirava Bio BV, our Dutch (...)
See more +

EU Joint Clinical Assessment (JCA): What US Biotechs Need to Know

The EU HTA Regulation introduces a mandatory Joint Clinical Assessment (...)
See more +

Early Access in Europe: Generating Revenue Before Marketing Authorisation

France, Italy, Germany and Switzerland all run early-access schemes that (...)
See more +

From Phase 2 Readout to a European Pricing Agreement: The 10 Gates

A decision-gated map of the European pathway for rare disease, (...)
See more +
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.